$26.67
-1.23 (-4.41%)
CVI News3 articles
Sumitomo Electric's Rally Raises Fair Value Questions Amid Pullback
Sumitomo Electric stock surged 300% in 12 months but pulled back 15.7% last week, trading near its DCF fair value of ¥10,975. CVR Energy and Icahn Enterprises also show mixed valuation signals.
Apellis Delisted After Biogen Buyout; CVR Payout in Focus
Apellis Pharmaceuticals has been delisted from Nasdaq following Biogen's completed acquisition. Shareholders get $41 per share plus a contingent value right worth up to $4 if Syfovre meets sales goals.
Biogen Closes Apellis Takeover; CVR Offers Upside
Biogen completed its $41/share cash acquisition of Apellis, delisting the stock from Nasdaq. Shareholders also received a contingent value right that could pay up to $4 if Syfovre sales hit targets.